Lv71
3250 积分 2023-08-02 加入
2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
15天前
已完结
Asundexian for Secondary Stroke Prevention
3个月前
已完结
Asundexian for Secondary Stroke Prevention
3个月前
已完结
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
Efficacy and safety of REGN9933(A2) and REGN7508(Cat) for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
5个月前
已关闭
Factor XIa inhibition as a therapeutic strategy for atherothrombosis
6个月前
已完结
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions
6个月前
已完结
Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generation
6个月前
已关闭
Long-Acting Factor XI Inhibition and Periprocedural Bleeding
6个月前
已完结
Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generation
7个月前
已关闭
皖公网安备34019202002308
